Thomas Andrew Rowland sold $36k of ANIP
SVP, HEAD - ESTABLISHED BRANDS at ANI PHARMACEUTICALS INC. 459 shares at an average of $79.21, traded May 12, 2026, filed May 13, 2026.
Score components
- +15RoleOfficer
- +6Trade size$36k at market
- 0Share of holdings soldSold 1.2% of holdings
- +15Cluster5 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +1.0%, 3m -7.1%, 6m -.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001507496-26-000012, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 12, 2026 | SOpen-market sale Common Stock | -459 | $79.21 | $36k | 38,271 | May 13, 2026 |
Related signals
Other insiders at ANI PHARMACEUTICALS INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| Pro nowfree Oct 21, 2026 | ANI PHARMACEUTICALS INC | Meredith Cook SR. VP, GENERAL COUNSEL & SEC. | $37k 500 shares | -1% | |
| 29Weak | ANI PHARMACEUTICALS INC | Stephen P. Carey SVP & CFO | $208k 2,850 shares | -2% | |
| 36Weak | ANI PHARMACEUTICALS INC | Nikhil Lalwani PRESIDENT & CEO | $383k 5,400 shares | -2% | |
| 18Weak | ANI PHARMACEUTICALS INC | Jeanne Thoma director | $72k 1,000 shares | -4% | |
| 16Weak | ANI PHARMACEUTICALS INC | Meredith Cook SR. VP, GENERAL COUNSEL & SEC. | $35k 500 shares | -1% | |
| 29Weak | ANI PHARMACEUTICALS INC | Stephen P. Carey SVP & CFO | $207k 2,850 shares | -2% | |
| 36Weak | ANI PHARMACEUTICALS INC | Nikhil Lalwani PRESIDENT & CEO | $401k 5,400 shares | -2% | |
| 16Weak | ANI PHARMACEUTICALS INC | Meredith Cook SR. VP, GENERAL COUNSEL & SEC. | $38k 500 shares | -1% | |
| 43Moderate | ANI PHARMACEUTICALS INC | Ori Gutwerg SVP, GENERICS | $243k 3,162 shares | -4% | |
| 23Weak | ANI PHARMACEUTICALS INC | Stephen P. Carey SVP & CFO | $232k 2,850 shares | -2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.